Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Option Care Health
OPCH
$3.54B
| $326K | ﹤0.01% |
11,750
-15,529
| -57% | -$442K |
|
|
NGM
3027
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $326K | ﹤0.01% |
25,436
+6,065
| +31% | +$84K |
|
3028
First Bank
FRBA
$458M
| $324K | ﹤0.01% |
23,155
+2,769
| +14% | +$39.1K |
|
3029
DigitalOcean
DOCN
$14.4B
| $323K | ﹤0.01% |
7,819
-7,251
| -48% | -$323K |
|
|
PLL
3030
DELISTED
Piedmont Lithium
PLL
| $323K | ﹤0.01% |
8,871
-6,588
| -43% | -$390K |
|
3031
Suburban Propane Partners
SPH
$1.18B
| $323K | ﹤0.01% |
21,210
+7,181
| +51% | +$119K |
|
3032
Cactus
WHD
$5.5B
| $323K | ﹤0.01% |
8,014
-8,683
| -52% | -$437K |
|
3033
Neogen
NEOG
$2.46B
| $322K | ﹤0.01% |
13,342
-10,489
| -44% | -$281K |
|
3034
Sprott Physical Silver Trust
PSLV
$12.8B
| $322K | ﹤0.01% |
46,656
| – | – |
|
|
TVRD
3035
Tvardi Therapeutics
TVRD
$23.1M
| $322K | ﹤0.01% |
979
-155
| -14% | -$54.4K |
|
|
SWTX
3036
DELISTED
SpringWorks Therapeutics
SWTX
| $321K | ﹤0.01% |
13,036
-13,896
| -52% | -$508K |
|
3037
GH Research
GHRS
$2.1B
| $320K | ﹤0.01% |
32,090
-2,002
| -6% | -$26K |
|
3038
Miller Industries
MLR
$620M
| $320K | ﹤0.01% |
14,103
+2,495
| +21% | +$63.4K |
|
3039
NextCure
NXTC
$22.7M
| $320K | ﹤0.01% |
5,674
-400
| -7% | -$20.9K |
|
|
HNGR
3040
DELISTED
Hanger Inc.
HNGR
| $320K | ﹤0.01% |
22,374
-16,847
| -43% | -$273K |
|
3041
AtaiBeckley Inc
ATAI
$2.66B
| $319K | ﹤0.01% |
87,832
+87,755
| +113,968% | +$359K |
|
3042
Ooma
OOMA
$588M
| $318K | ﹤0.01% |
26,850
+4,490
| +20% | +$59.6K |
|
3043
Invesco WilderHill Clean Energy ETF
PBW
$414M
| $317K | ﹤0.01% |
6,928
+6,580
| +1,891% | +$345K |
|
3044
Relmada Therapeutics
RLMD
$564M
| $317K | ﹤0.01% |
16,699
+14,999
| +882% | +$327K |
|
3045
Core Laboratories
CLB
$513M
| $315K | ﹤0.01% |
15,897
-17,508
| -52% | -$465K |
|
|
TBRG
3046
DELISTED
TruBridge
TBRG
| $315K | ﹤0.01% |
9,867
-5,585
| -36% | -$181K |
|
|
ABTX
3047
DELISTED
Allegiance Bancshares
ABTX
| $315K | ﹤0.01% |
8,333
-18,514
| -69% | -$744K |
|
|
NVAC
3048
DELISTED
NorthView Acquisition Corporation Common Stock
NVAC
| $315K | ﹤0.01% |
31,851
| – | – |
|
3049
AMERISAFE
AMSF
$551M
| $313K | ﹤0.01% |
6,026
-9,564
| -61% | -$466K |
|
3050
Amerant Bancorp
AMTB
$1.14B
| $313K | ﹤0.01% |
11,100
+3,301
| +42% | +$93.6K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.